Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, cilt.27, sa.12, ss.1033-6, 2011 (SCI-Expanded)
Background. To evaluate the effect of risedronate treatment on osteoprotegerin (OPG), C-terminal cross-linking telopeptide of type 1 collagen (CTX), osteocalcin (OC), and deoxypyridinoline (DPD).